Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies.

52W Range

13thpctl

Volume

0.22×avg

Market Cap

69.21MUSD

P/E Ratio

-1.5TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

XBiotech Inc.

XBITNASDAQ Global Select·USD·Closed

XBiotech Inc.

XBITNASDAQ·USD·Closed

$2.27

−1.30%

$2.27

−$0.03 (1.30%)

52W Range

13thpctl

Volume

0.22×avg

Mkt Cap

69.21MUSD

P/E

-1.5TTM

Div Yield

–ann

XBIT: XBiotech Inc. Stock Analysis | finqOS